Literature DB >> 11971183

Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype.

Maria-Emily R Gapuzan1, Pavel V Yufit, Thomas D Gilmore.   

Abstract

The RelA transcription factor is part of dimeric complexes, most commonly either p50-RelA (NF-kappaB) heterodimers or RelA homodimers, that control a variety of cellular processes. Immortalized embryonic fibroblasts established from rela knockout mice have previously been shown to be more sensitive to apoptosis induced by tumor necrosis factor (TNF) than are control fibroblasts. In this report, we show that one line of rela-/- fibroblasts has additional phenotypes that distinguish them from control mouse fibroblasts. As compared to normal 3T3 cells, RelA-deficient fibroblasts have a spindled morphology, are less adherent to culture dishes, grow to a higher saturation density, and can form colonies in soft agar. These properties are consistent with a weakly transformed phenotype for rela-/- cells. Furthermore, RelA-deficient fibroblasts can form tumors in immunodeficient mice, but these tumors regress, probably because of the sensitivity of these cells to TNF. The ability of rela-/- fibroblasts to form colonies in soft agar can be reverted by re-expression of wild-type mouse RelA, but not by expression of RelA mutants that cannot form homodimers. There is no clear correlation between the absence of RelA and the levels of expression of other Rel/NF-kappaB family members or adhesion proteins (ICAM-1 and VCAM-1) whose genes have upstream kappaB sites. Taken together, these results suggest that RelA has tumor suppressing activity under some circumstances and that RelA complexes are involved in the control of a variety of cellular properties associated with oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971183     DOI: 10.1038/sj.onc.1205333

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.

Authors:  Sharmistha Pal; Sheethal N Vishwanath; Hediye Erdjument-Bromage; Paul Tempst; Saïd Sif
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Authors:  Emilie Jacque; Thierry Tchenio; Guillaume Piton; Paul-Henri Romeo; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

3.  Targeting of several glycolytic enzymes using RNA interference reveals aldolase affects cancer cell proliferation through a non-glycolytic mechanism.

Authors:  Carolyn Ritterson Lew; Dean R Tolan
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

4.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

Review 5.  Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades.

Authors:  Z Yang; L Song; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

6.  Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.

Authors:  M Chin; M Herscovitch; N Zhang; D J Waxman; T D Gilmore
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

7.  Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347.

Authors:  Melanie Herscovitch; William Comb; Thomas Ennis; Kate Coleman; Sheila Yong; Brinda Armstead; Demetrios Kalaitzidis; Sushil Chandani; Thomas D Gilmore
Journal:  Biochem Biophys Res Commun       Date:  2007-12-28       Impact factor: 3.575

8.  Mutation of nonessential cysteines shows that the NF-κB essential modulator forms a constitutive noncovalent dimer that binds IκB kinase-β with high affinity.

Authors:  Shaun M Cote; Thomas D Gilmore; Robert Shaffer; Urs Weber; Rishitha Bollam; Mary S Golden; Kimberley Glover; Melanie Herscovitch; Thomas Ennis; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

9.  A role for IkappaB kinase 2 in bipolar spindle assembly.

Authors:  Jeffrey T Irelan; Thomas J Murphy; Paul D DeJesus; Hsiangling Teo; Dingyue Xu; Maria A Gomez-Ferreria; Yingyao Zhou; Loren J Miraglia; Daniel R Rines; Inder M Verma; David J Sharp; Vinay Tergaonkar; Sumit K Chanda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-15       Impact factor: 11.205

10.  Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.

Authors:  Robert Valentine; Christopher W Dawson; Chunfang Hu; Khilan M Shah; Thomas J Owen; Kathryn L Date; Sonia P Maia; Jianyong Shao; John R Arrand; Lawrence S Young; John D O'Neil
Journal:  Mol Cancer       Date:  2010-01-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.